stockrowZimmer Biomet Holdings, Inc.
ZBH Healthcare Medical Devices
Zimmer Biomet Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $8.2 billion, up 7.20% from fiscal 2024.
- Revenue
- +3.07%
- EPS
- −13.5%
- Free cash flow
- +29.8%
- Total debt
- −7.50%
Quarter to September 2026, against a year earlier
Follow ZBH
Alert me
Zimmer Biomet Holdings, Inc. (ZBH) Operating cash flow
Zimmer Biomet Holdings, Inc.'s operating cash flow for fiscal 2025 was $1.7B, up 13.2% from $1.5B in fiscal 2024. Over the twelve months to 30 September 2026 it was $1.9B. Over the past ten years it has ranged from $849.8M (fiscal 2015) to $1.7B (fiscal 2018); the current reading is higher than 91% of that period. Zimmer Biomet Holdings, Inc. ranks 8th of 149 Medical Devices companies by operating cash flow.
Operating cash flow, annual
Embed this chart
Annual newest first
| Period | Operating cash flow | Change |
|---|---|---|
| FY2025 | $1.7B | 13.19% |
| FY2024 | $1.5B | (5.20%) |
| FY2023 | $1.6B | 16.62% |
| FY2022 | $1.4B | (3.43%) |
| FY2021 | $1.4B | 30.56% |
| FY2020 | $1.1B | (32.17%) |
| FY2019 | $1.6B | (9.25%) |
| FY2018 | $1.7B | 10.43% |
| FY2017 | $1.6B | (3.06%) |
| FY2016 | $1.6B | 92.07% |
Quarterly newest first
| Period | Operating cash flow | Change |
|---|---|---|
| Sep 2026 | $560.0M | 25.06% |
| Jun 2026 | $447.8M | 24.60% |
| Mar 2026 | $359.4M | (30.54%) |
| Dec 2025 | $517.4M | 23.57% |
| 43 more quarters | Free account |
Against its own ten years
Operating cash flow against peers
| Company | Operating cash flow |
|---|---|
| SNN Smith & Nephew SNATS, Inc. compare | $3.1B |
| PHG Koninklijke Philips N.V. compare | $2.9B |
| ZBH Zimmer Biomet Holdings, Inc. | $1.9B |
| DXCM DexCom, Inc. compare | $1.4B |
| STE STERIS plc compare | $1.3B |
| GMED Globus Medical, Inc. compare | $925.9M |
| PODD Insulet Corporation compare | $509.0M |
| PEN Penumbra, Inc. compare | $261.0M |
| GKOS Glaukos Corporation compare | $47.7M |
What Operating cash flow is
Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.
Reported line item
More on ZBH
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement